Category: Qui Tam

ATTORNEY NEWSLETTER Whistleblowing employees face unique challenges in building qui tam cases against their employers for violations of the False Claims Act. Challenges such as shielding oneself from workplace retaliation, the perils of internally reporting the violations, making the choice to undertake an internal investigation and risks faced while negotiating […]

ATTORNEY NEWSLETTER A large Indian pharmaceutical manufacturer has agreed to settle with the United States and states’ attorneys general in a whistleblower lawsuit.  The pharmaceutical manufacturer was alleged to have falsified data, violated Current Good Manufacturing and Laboratory Practices, and sold substandard and unapproved drugs.  This settlement happened due of […]

ATTORNEY NEWSLETTER In November of 2012 congress unanimously approved the passage of the whistleblowers could not protect themselves against associated retaliation by employers because of loopholes by the Federal Circuit Court of Appeals.  By passing the Whistleblower Protection Enhancement Act, congress acknowledged that bad administrative and court rulings had undermined […]

ATTORNEY NEWSLETTER Exposing an organization’s misconduct or illegal activities requires courage. Employees who risk their professional careers by coming forward to report and help remedy illegal conduct are referred to as “whistleblowers.” After reporting the misconduct to the Internal Revenue Service (IRS), whistleblowers often finds themselves patiently waiting for a […]

ATTORNEY NEWSLETTER In the past, the Food and Drug Administration (FDA) took the lead role in investigating pharmaceutical manufacturing facilities for violations of good manufacturing practices (cGMP’s).  Recently, the Department of Justice (DOJ) became a more actively involved in enforcement actions against pharmaceutical manufacturing facilities due to whistleblowers.  The DOJ […]

ATTORNEY NEWSLETTER         One lawsuit against Novartis alleges that the pharmaceutical company paid kickbacks to doctors to induce them to prescribe Novartis products over those from other companies.  Those Novartis products were then reimbursed by federal health care programs.  As a result, the federal government is alleged to have paid […]

  ATTORNEY NEWSLETTER Banks Aid in Fraud Against Older Consumers Anyone can be targeted by unscrupulous marketers.  However, for a variety of reasons, older people are particularly vulnerable to deceptive pitches that arrive by telephone, mail, and the Internet.  Mass market fraud operations are commonplace in this country.  A recent […]

–ATTORNEY NEWSLETTER- An IRS or tax fraud whistleblower is a person who tells the public about alleged illegal activities or misconduct in a government department or private company including those that commit tax fraud.  If you are a whistleblower for tax fraud or other types of fraud where the government […]

-ATTORNEY NEWSLETTER- Congress instituted The False Claims Act (FCA) in order to hold individuals and businesses accountable if they partake in fraudulent activity regarding government entities. Individuals, called whistleblowers are urged to bring these claims to court on behalf of the government. Whistleblowers are imperative in providing such information to […]

-ATTORNEY NEWSLETTER- A whistle blower is a person who reveals some type of dishonest or illegal activity within an organization to the public or someone with authority. Being a whistleblower can sometime mean that you must stand alone. If you find yourself or an employee in a position where the […]